AI Science Tracker
EN

Multiparametric MRI-based radiomics combined with deep learning for preoperative risk stratification of endometrial carcinoma.

Department of Radiology, The First People’s Hospital of Qinzhou, China; Department of Medical Imaging, Jinjiang Municipal Hospital, China; Department of Radiology, Guigang City People’s Hospital, China; Department of Radiology, Affiliated Hospital of Youjiang Medical University for Nationalities, China · 22 Oct 2026 · medicine

Discovery

Multiparametric MRI-based radiomics combined with deep learning for preoperative risk stratification of endometrial carcinoma.

Source check: Source checked. Not independent scientific confirmation.

Finding: The combined model reports validation AUC 0.891 and related discrimination metrics.

Technology: Combined MRI radiomics, deep-learning, clinical, and semantic features were modeled for endometrial-cancer risk

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Combined MRI radiomics, deep-learning, clinical, and semantic features were modeled for endometrial-cancer risk.
Test and result
The combined model reports validation AUC 0.891 and related discrimination metrics. Evaluation: Validation-set performance was reported; the relevant MRI cohort and reference standard need cautious interpretation.
Limitation / still unknown
The reported AUC is cohort- and reference-standard-specific; prospective clinical utility is not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fonc.2026.1942153

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.